Tacstick 0.75 Capsule contains Tacrolimus 0.75 mg, a potent calcineurin inhibitor and immunosuppressant widely used in organ transplant medicine to prevent graft rejection.
This capsule works by inhibiting T-lymphocyte activation via calcineurin suppression, reducing immune-mediated damage to transplanted organs. It is ideal for patients requiring precise low-dose immunosuppression under specialist supervision.
Clinically, Tacstick 0.75 Capsule is used in renal, hepatic, and cardiac transplant protocols, often in combination with corticosteroids and other immunosuppressive agents, to maintain graft survival and minimize rejection episodes.
The capsule ensures accurate dosing, consistent bioavailability, and reliable therapeutic outcomes, making it suitable for hospitals, transplant centers, specialty pharmacies, and clinics managing post-transplant immunosuppressive therapy.